Skip to content

AI Colorectal Polyp Detection

Colorectal Polyp Detection Comparing Computer Assisted Colonoscopy With Conventional Colonoscopy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04979962
Enrollment
1162
Registered
2021-07-28
Start date
2021-11-24
Completion date
2022-11-21
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenoma Colon, Polyp Colorectal

Brief summary

This study is intended to demonstrate the superiority of colorectal polyp detection using computer-assisted colonoscopy compared to conventional colonoscopy.

Interventions

DEVICEEW10-EC02 (Endoscopy Support Program)

EW10-EC02 is intended to automatically detect the location of suspected polyps in colonoscopy exams. Identified polyps are highlighted to the clinician in real-time during the exam, as a video image superimposed on the endoscope monitor. EW10-EC02 is limited to the detection of suspected findings, and should not be used in lieu of full patient evaluation or relied upon to make or confirm a diagnosis.

Sponsors

Fujifilm Medical Systems USA, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Masking description

Patients will be randomized 1:1, inspection with computer assisted colonoscopy: inspection with conventional colonoscopy.

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Average risk subjects undergoing their first colonoscopy (screening) or follow-up colonoscopy for previous history of polyps (surveillance interval of 3 years or greater) * Patients aged 45 or older * Patients who can provide an informed consent

Exclusion criteria

* Patients with history of colon resection, Inflammatory Bowel Disease (IBD), Familial Adenomatous Polyposis (FAP), severe comorbidity, including end-stage cardiovascular/pulmonary/liver/renal disease * Patients who are pregnant or are planning pregnancy during study period * Patients who are not able to or refuse to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Adenoma per colonoscopy (APC)1 day/procedureTotal number of histologically confirmed adenomas and carcinomas detected in the colonoscopy divided by the total number of colonoscopies

Secondary

MeasureTime frameDescription
Positive predictive value (PPV)1 day/procedureTotal number of histologically confirmed adenomas and carcinomas detected during the colonoscopy, divided by the total number of excisions in the colonoscopy
Adenoma detection rate (ADR)1 day/procedureproportion of patients with at least one histologically confirmed adenoma or carcinoma detected in the colonoscopy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026